Fairvalue-Calculator Fairvalue-Calculator
EN DE

Pro-Dex, Inc (PDEX) Fair Value & Analysis

Healthcare · US · Market cap $206M

Price$63.39
Fair Value$33.97
Upside-46.4%
Quality95/100
Evidence: High Range $19.12 – $64.54

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Pro-Dex, Inc (PDEX) currently trades at $63.39, while our model-based Fair Value estimate is $33.97 — implying the stock looks roughly 46.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Pro-Dex, Inc (PDEX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $33.97 versus a price of $63.39 — about −46% (overvalued). Model-based estimate, not financial advice.
What is the fair value of PDEX?
Our 21-model fair value for Pro-Dex, Inc is $33.97 (as of Jun 24, 2026), built from audited fundamentals. The current price is $63.39.
What is the quality score of PDEX?
Pro-Dex, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.